等待開盤 04-03 09:30:00 美东时间
0.000
NaN.00%
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 92.55 percent increase over losses of $(1.61) per share from the same
03-31 18:19
BRIEF-LENSAR Q4 Net Income USD -1.5 Million Mar 31 (Reuters) - LENSAR Q4 EBITDA USD -400 thousand.
03-31 18:00
BTIG analyst Ryan Zimmerman upgrades LENSAR (NASDAQ:LNSR) from Neutral to Buy and announces $10 price target.
03-18 17:50
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
03-17 21:04
LENSAR ( ($LNSR) ) just unveiled an announcement. On March 16, 2026, LENSAR, In...
03-17 20:50
Stock futures edged lower Tuesday premarket, while oil prices ticked higher amid the ongoing Iran war. Here are some of Tuesday's biggest stock movers: Biggest stock gainers New Era Energy (NUAI) +9% ...
03-17 17:01
Lensar (LNSR) reached an agreement with Alcon (ALC) to terminate its planned sale. The parties are abandoning the deal as the Federal Trade Commission is expected to block the merger agreement, accor...
03-17 04:58
LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced that it reached an agreement with Alcon
03-17 04:40
<p>LENSAR, Inc. announced the termination of its merger agreement with Alcon Research, LLC due to the Federal Trade Commission's intent to block the acquisition and the unlikelihood of obtaining U.S. regulatory approvals by the extended deadline of July 23, 2026. LENSAR will retain the $10 million deposit from Alcon. Despite the disappointment, the company remains focused on advancing its ALLY Robotic Cataract Laser System™ and driving global gro...
03-16 20:30